58 Excluding treg epitopes and integrating CD8 and CD4 effector neoepitope content improves prognostic biomarker tool in bladder cancer

• Michael Princiotta,
• Arjun Balar,
• Gary Steinberg,
• Randy Sweis,
• Guilhem Richard,
• Tzintzuni Garcia,
• Matthew Ardito,
• William Martin,
• Gad Berdugo,
• Anne de Groot

Affiliations

Michael Princiotta

Aff175 Advaxis Immunotherapies Princeton NJ USA

Arjun Balar

Aff2 0000 0004 1936 8753grid.137628.9Laura and Isaac Perlmutter Cancer CenterNYU Langone Health New York NY USA

Gary Steinberg

Aff1 grid.412578.d0000000087369513University of Chicago Medical Center Chicago IL USA

Randy Sweis

8University of Chicago, Chicago, IL, USA

Guilhem Richard

1EpiVax Oncology, Inc., Providence, RI, USA

Tzintzuni Garcia

3University of Chicago, Chicago, IL, USA

Matthew Ardito

4EpiVax, Inc., Providence, RI, USA

William Martin

4EpiVax, Inc., Providence, RI, USA

Gad Berdugo

1EpiVax Oncology, Inc., Providence, RI, USA

Anne de Groot

4EpiVax, Inc., Providence, RI, USA